Research Article
Low GAS5 Levels as a Predictor of Poor Survival in Patients with Lower-Grade Gliomas
Table 1
The associations between GAS5 expression and pathological parameters in patients.
| Attributesā GAS expression and ā¦ | GBM | LGG | Statistic | P-value | FDR (BH) | Statistic | P-value | FDR (BH) |
| Ethnicity (Wilcox test) | 0.096 | 0.620 | 0.843 | 0.002 | 0.487 | 0.487 |
| Histological type (Kruskal-Wallis test) | 2.467 | 0.291 | 0.843 | 3.918 | 0.141 | 0.197 |
| Race (Kruskal-Wallis test) | 1.110 | 0.574 | 0.843 | 4.180 | 0.243 | 0.283 |
| Radiation therapy (Wilcox test) | -0.003 | 0.843 | 0.843 | -0.025 | 0.019 | 0.045 |
| Tumour purity (Spearman correlation) | -0.023 | 0.785 | 0.843 | 0.300 | 1.775e-11 | 1.243e-10 |
| Age (Spearman correlation) | -0.064 | 0.446 | 0.843 | -0.093 | 0.041 | 0.073 |
|
|